Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-u

Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-u

Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial

By Medevise Consulting

Date and time

Location

Palais des Congrès de Paris

2 Place de la Porte Maillot 75017 Paris France

About this event

  • Event lasts 1 hour

Agenda:

· 10:15 - 10:20 Quan Dong Nguyen, MD, MSc, US - Welcome & Introductions

· 10:20 - 10:30 Pr Laurent Kodjikian MD, PhD, FEBO, France – Photobiomodulation Therapy: Proposed Mechanisms for Ocular Disease and Injury

· 10:30 - 10:45 Diana Do, MD, USA - Clinical Findings from the LIGHTSITE III and IIIB Extension Trials

· 10:45 - 11:00 Prof. Marion Munk, M.D., Ph.D, Switzerland - Supporting Evidence for Photobiomodulation Use in Ocular Conditions

· 11:00 - 11:15 Quan Dong Nguyen, MD, MSc, US - Q&A Discussion

Organized by

FreeSep 6 · 10:15 AM GMT+2